GH1 and amyotrophic lateral sclerosis: Finally, even when according to one report (Morselli et al., 2006) the majority of ALS patients showed deficiencies in growth hormone secretion, in a recent clinical trial the administration of this hormone to ALS patients did not produce any benefit as compared to patients that received placebo (Saccà et al., 2012).